Neuropharmacological Advances: Harnessing 5-HT2A Receptor Modulators and Psychoplastogens.
Robert B KargboPublished in: ACS medicinal chemistry letters (2024)
This Patent Highlight explores the emerging role of 5-HT2A receptor modulators and psychoplastogens in neuropsychiatric treatment. It delves into these novel compounds' molecular mechanisms, therapeutic potential, and challenges, highlighting their therapeutic potential in mental health care.
Keyphrases